Type
Blood Testing
Biomarkers
8
Duration
10 min
Results
48 hours
Glycated haemoglobin (HbA1c) measurement reflecting average blood glucose control over the preceding 8-12 weeks. The primary monitoring marker for diabetes management and an independent diagnostic criterion for type 2 diabetes. At 38 PLN (~8.80 EUR), a cost-effective way to assess long-term glycaemic status without the variability of single fasting glucose measurements.
HbA1c measures the percentage of haemoglobin molecules that have undergone non-enzymatic glycation — a chemical reaction proportional to ambient blood glucose concentration over the lifespan of red blood cells (approximately 120 days). This provides a time-averaged picture of glycaemic control that is unaffected by meal timing, acute stress, or day-to-day glucose fluctuations. The World Health Organization and American Diabetes Association both accept HbA1c as a diagnostic criterion for diabetes mellitus. An HbA1c of 6.5% (48 mmol/mol) or above is diagnostic of diabetes. Values between 5.7-6.4% (39-47 mmol/mol) indicate pre-diabetes — a high-risk state where lifestyle intervention can reduce progression to overt diabetes by 58%, according to the landmark Diabetes Prevention Program trial. For patients already diagnosed with diabetes, HbA1c is the primary tool for monitoring treatment effectiveness. European Association for the Study of Diabetes guidelines recommend a target below 7.0% (53 mmol/mol) for most adults, with individualisation based on age, comorbidities, and hypoglycaemia risk. Each 1% reduction in HbA1c is associated with approximately 21% reduction in diabetes-related endpoints. The test does not require fasting, making it more convenient than fasting glucose or oral glucose tolerance tests. However, results can be affected by conditions that alter red blood cell turnover — haemolytic anaemia, recent transfusion, iron deficiency, or haemoglobin variants may produce misleading values. At 38 PLN, InterLab offers this test at roughly one-third the price of German private laboratory fees. The 5 PLN per-visit collection fee applies.
Key Details
- Biomarker
- HbA1c
- Results
- 1-2 days
- Fasting
- Not required
Who Is This For?
Diabetes screening, diabetes monitoring, pre-diabetes detection, long-term glucose assessment
What's Included
Preparation Required
No fasting required. Can be drawn at any time of day.
Panel Categories
Biomarkers Tested
8A byproduct of insulin production, released in equal amounts to insulin. C-peptide measures how much insulin your pancreas is producing, helping distinguish between type 1 and type 2 diabetes.
If you have diabetes your body doesn't process glucose effectively.
A hormone produced by the pancreas that helps to control blood glucose levels and plays a role in controlling the levels of carbohydrates and fats stored in the body.
Blood sugar — the body's primary energy source. Fasting glucose screens for diabetes and prediabetes. Chronically elevated glucose damages blood vessels and organs. Levels fluctuate with meals, stress, and physical activity.
The iron-rich protein in red blood cells responsible for carrying oxygen throughout your body and returning carbon dioxide to the lungs. Low haemoglobin is the primary marker for anemia and can cause fatigue, weakness, and shortness of breath.
Reflects your average blood sugar over the past 2–3 months by measuring the percentage of hemoglobin with attached glucose. HbA1c is the gold standard for diagnosing and monitoring diabetes, unaffected by daily fluctuations.
Calculated score assessing insulin resistance based on fasting glucose and insulin levels.
The hormone produced by the pancreas to regulate blood sugar. Elevated fasting insulin — even with normal glucose — is an early marker of insulin resistance, which precedes type 2 diabetes by years. Key biomarker in longevity medicine.
38 PLN for HbA1c. A 5 PLN per-visit blood collection fee applies.
- Category
- Diagnostic
- Sample Type
- Blood (venous draw)
- Duration
- 10 min
- Results
- 48 hours